Cencora (COR) completed the acquisition of Retina Consultants of America for $4.4 billion in cash, subject to a customary post-closing price adjustment.
Fiscal 2025 adjusted earnings guidance was boosted to the range of $15.15 to $15.45 a share from $14.80 to $15.10 to reflect the acquisition, Cencora said Thursday in a statement.
The company acquired 85% in RCA, while some RCA physicians and managers retained a minority stake.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。